1 Atrial fibrillation is associated with a heightened risk of thromboembolism such as stroke and other cardiovascular events that puts patients at a substantially increased risk of morbidity and mortality. From January 1 through December 31, 2019, 123 adult patients who received diltiazem in the ED for AFIB-RVR were identified